News

Samsung Biologics Announces Major Manufacturing Partnership

Samsung Biologics Announces Major Manufacturing Partnership

Samsung Biologics Partners with European Pharmaceutical Leader

Samsung Biologics (KRX: 207940.KS) has recently made headlines by securing a substantial manufacturing agreement with a prominent European pharmaceutical company. This deal signifies the organization’s commitment to providing top-tier biomanufacturing services and will extend through 2031, with a total value exceeding USD 668 million.

Significant Milestones in Contract Values

The cumulative contract value for Samsung Biologics in 2024 is forecasted to surpass USD 4 billion following these latest agreements. Such milestones reflect the growing trust and collaboration that Samsung Biologics has cultivated with its partners in the biopharmaceutical industry.

Ongoing Expansion of Services

According to John Rim, President and CEO of Samsung Biologics, "We are delighted to expand our partnership with the European pharmaceutical company toward our shared commitment to delivering high-quality biopharmaceuticals to patients." This statement emphasizes the company’s dedication to craftsmanship and technological advancement, demonstrating a proactive approach to meeting the needs of the industry.

Strategic Partnerships Across the Globe

2024 has been a pivotal year for Samsung Biologics as it has successfully established new contracts and solidified relationships with existing clients across the U.S., Asia, and Europe. Currently, Samsung Biologics is proud to partner with 17 of the top 20 pharmaceutical companies worldwide, showcasing its prominence in the biomanufacturing landscape.

Investment in Advanced Facilities and Technologies

As part of its strategy for growth, Samsung Biologics plans to introduce antibody-drug conjugate (ADC) services, which will be operational by the end of the year. This initiative will include a dedicated facility for ADC process development, reinforcing Samsung Biologics’ expertise in biologics and antibody manufacturing.

Continuation of Biomanufacturing Expansion

Furthermore, the company is preparing for the inauguration of Bio Campus II next year, with Plant 5 projected to begin operations by April 2025. This expansion indicates the company’s foresight in meeting the rising demand for biomanufacturing capabilities.

About Samsung Biologics Co., Ltd.

Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) that offers a complete suite of services, from cell line development to final aseptic fill and finish. The company prides itself on state-of-the-art, CGMP-compliant facilities equipped with bioreactors of various sizes, catering to diverse client needs. To support its growing operations, Samsung Biologics continues to invest in new technologies, including dedicated facilities for mRNA and ADC manufacturing, ensuring it remains a leading CDMO partner in the biopharmaceutical sector.

Frequently Asked Questions

What recent deal has Samsung Biologics signed?

Samsung Biologics has signed a manufacturing deal with a European pharmaceutical company, valued at over USD 668 million.

How much is Samsung Biologics' cumulative contract value for 2024?

The cumulative contract value for 2024 is expected to exceed USD 4 billion.

What services will Samsung Biologics add to its portfolio?

The company plans to add antibody-drug conjugate (ADC) services, enhancing its capabilities in biomanufacturing.

When will Plant 5 in Bio Campus II be operational?

Plant 5 is projected to be operational by April 2025, reinforcing the company's manufacturing capacity.

How many top pharmaceutical companies does Samsung Biologics partner with?

Samsung Biologics partners with 17 of the top 20 pharmaceutical companies worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Navigating New Home Builds: Tucson’s Precise Timelines

Updated Category News Views 15

Building a Home in Tucson: Timing is Everything Ask anyone who's ever dreamed of their own custom-built home—patience isn't just a virtue, it's a necessity. In Tucson, Arizona, where the landscape is as captivating as it is challenging, Home Remodeling Expert Robin Hartman breaks down exactly what homeowners should expect when embarking on a home build. Hartman, through...

Continue Reading
Ebix and intentyx Tackle AI Security in Regulated Fields

Updated Category News Views 115

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

Continue Reading
PSEG Q3 2026: Mixed Earnings Amidst Storms and Stability

Updated Category News Views 45

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

Continue Reading
LITEON's Q3 Surge: Record Profits, AI Focus Amplified

Updated Category News Views 53

LITEON Smashes Q3 Records, Financials Speak Volumes You don't find numbers like these under every rock. LITEON Technology is rolling in it after clinching third quarter revenues of NT$57.4 billion, marking a significant 9% growth compared to the previous quarter and a whopping 28% surge year-over-year. That's the kind of financial football that gets investors holding onto...

Continue Reading
Nexus Capital Buys Coldwater Creek, Eyes Growth Surge

Updated Category News Views 0

A New Chapter in Apparel Investment You know when you're flipping through those catalog pages or hitting up e-commerce sites, just to find that perfect piece of clothing for a special someone—and you stick with a brand not just outta habit, but 'cause they've got a piece of your history? That's Coldwater Creek and Soft Surroundings, two brands that's been keepin' their...

Continue Reading
UFC Gym Expands, Opening Murfreesboro Location Soon

Updated Category News Views 20

UFC GYM Targets the Heart of Murfreesboro They're doing it again—UFC GYM's tossing another gym into the mix, folks! This time, it's Murfreesboro, Tennessee, catching the brand's punchy, high-energy splash. Don't mistake this for just another big-box, bench-press-jamboree. Their doors swing open come November 14, and this ain't some punk move. We're talking a whopping...

Continue Reading
Brightstar Showcases at World Lottery Summit 2026

Updated Category News Views 158

Brightstar Aims for the Jackpot at WLS 2026 Don't kid yourself—this isn't your granddad's corner-store lottery ticket. Brightstar Lottery PLC, trading as NYSE: BRSL, is pushing the envelope at the World Lottery Summit 2026 in Sydney, flaunting a roster of high-tech and savvy solutions to meet changing player expectations. It's a collision of tradition and tech, all...

Continue Reading
Apacer Unveils Cutting-Edge Storage at Electronica 2026

Updated Category News Views 38

Forging New Paths in Storage Tech Technology waits for no one, and Apacer knows it better than most. At electronica 2026, they're not just tossing out buzzwords—they're backing up promises with cold hard innovations. It's like watching a seasoned chess player thinking ten moves ahead in the game that is techno-evolution. This year, they've hitched a ride on the AI,...

Continue Reading
Zensar Sees Solid Revenue Growth in Q2FY27

Updated Category News Views 39

Zensar's Q2 Performance: Growth Amid Shifting Sands Is Zensar Technologies quietly carving a spot for itself in the cutthroat tech marketplace, or are we just seeing a temporary glimmer during a complex market scenario? With a constant currency growth rate of 4.1% in Q2FY27, Zensar sure seems to have gotten something right. But does this mean they’ve got the long-term...

Continue Reading
Lakeland Builds Apartments; Screening Rules Cause Snags

Updated Category News Views 31

What's the Real Trouble in Lakeland? The Lakeland metro area surely ain't short on apartments after a colossal building frenzy. We're talking a solid 40% bump in just the past five years. You'd figure that'd be enough to solve any housing squeeze, right? But here's the kicker: vacancy rates are stuck at 11.8% — way over the national mean of 7.9%. Discounts like two...

Continue Reading

Top 5 Most Recently Viewed Articles

Heineken Holding N.V. Updates on Share Buyback Progress

Updated Category News Views 190

Overview of Heineken's Share Buyback Programme Heineken Holding N.V., a renowned global brewer, is actively implementing its share buyback programme. This strategic decision, involving up to approximately €750 million, reflects the company’s commitment to enhancing shareholder value. The company recently shared exciting updates regarding its buyback initiatives,...

Continue Reading
MEXC's Exciting RedStone Listing with 300k USDT in Prizes

Updated Category News Views 142

MEXC's New Listing: RedStone (RED) and Its Celebration MEXC, a prominent name in the cryptocurrency exchange realm, is making headlines with the upcoming listing of RedStone (RED). This innovative Oracle solution aims to transform decentralized finance (DeFi) by providing cost-effective data feeds across over 50 blockchains. With significant backing from established...

Continue Reading
Loar Holdings Earnings Preview: What Investors Should Know

Updated Category News Views 105

Anticipating Loar Holdings' Earnings Release Loar Holdings (NYSE: LOAR) is preparing to announce its quarterly earnings soon. This announcement is crucial for investors looking to gauge the company's performance and future potential. Let’s delve into what investors should keep in mind before the upcoming financial release. Analyst Expectations and Predictions Analysts...

Continue Reading
Innovative Device Aims to Uplift Drivers' Spirits on the Road

Updated Category News Views 255

Introducing a Revolutionary Vehicle Accessory for Drivers In today's fast-paced world, driving can often become a stressful experience. Recognizing this challenge, an inventive mind has brought forth a unique solution to help mitigate driving anxiety. The DASHBOARD DAILY INSPIRATION is a vehicle accessory designed specifically to uplift the mood of drivers with positive...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 39

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading